Lepicortinolo

Prednisolone, the active ingredient in Lepicortinolo, is a glucocorticoid presented as an oral tablet for systemic use. It reduces inflammation and modulates immune responses, making it suitable for treating a range of inflammatory, allergic and autoimmune conditions in adult patients. It is used for both short‑term and chronic management and is administered under medical supervision to achieve optimal therapeutic outcomes while minimizing systemic exposure.

GNH USA supplies Lepicortinolo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established quality‑assurance processes and regulatory compliance across EU and other markets.

Prednisolone acts on inflammatory and immune pathways, providing therapeutic benefit across several disease categories. - Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility. - Asthma exacerbations: diminishes airway inflammation, aiding symptom control. - Systemic lupus erythematosus: suppresses autoimmune activity, decreasing disease flares. - Severe allergic reactions: mitigates hypersensitivity responses, relieving edema and urticaria.

Prednisolone may cause a range of adverse reactions, varying from mild, frequently observed effects to rare but potentially life‑threatening events. Common Side Effects: - Increased appetite: may lead to weight gain. - Mood changes: irritability or euphoria. - Insomnia: difficulty sleeping. - Gastrointestinal discomfort: nausea or dyspepsia. - Fluid retention: mild edema. Serious or Rare Side Effects: - Severe infection: heightened susceptibility. - Osteoporosis: bone density loss. - Adrenal suppression: cortisol axis inhibition.

When prescribing Prednisolone, clinicians should consider several precautionary measures to ensure patient safety. - Monitor blood glucose: check for hyperglycemia, especially in diabetics. - Assess infection risk: avoid use in active systemic infections. - Evaluate bone health: consider calcium/vitamin D supplementation. - Review psychiatric history: watch for mood swings or psychosis. - Taper gradually: prevent adrenal insufficiency upon discontinuation. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Prednisolone can interact with other medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Strong CYP3A4 inducers: reduce prednisolone levels (e.g., rifampicin, phenytoin). - Anticoagulants (warfarin): increase bleeding risk. - NSAIDs: elevate gastrointestinal ulcer risk. Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypokalemia. - Antidiabetic agents: may require dose adjustment due to hyperglycemia. - Vaccines: live vaccine efficacy may be diminished.